MS: Busting the Myths
November 28, 2023 | Research, Study, Treatments, Trials
MSNZ note this was a small trial and it’s in the very early stages but this is an interesting development in stem cell research. Doctors are cautiously hopeful about a new multiple sclerosis therapy after finding that injecting stem cells […]
November 14, 2023 | Education, Media, Research, Training, Treatments
In this report, Dr John Mottershead provides an overview of the recent MSMilan 2023 Conference he attended. In this review: – NGDs which mimic MS – Junior resident accuracy in recognising MS – Alternative diagnoses in suspected MS – Tapering of oral prednisone after […]
September 19, 2023 | Treatments
Mavenclad® Cladribine – Have your Say MSNZ is currently preparing a submission to Pharmac to urge them to again consider funding Mavenclad (Cladribine) for Relapsing Remitting MS. Our submission is due this Friday 22nd September. Real world and clinical trial […]
September 14, 2023 | Treatments
Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here: PPMS Ocrevus FAQ – 13 September 2023. What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)? There is only […]
September 4, 2023 | Advocacy, Media, Progressive, Treatments
A seven year battle on behalf of hundreds of people living with the most debilitating form of Multiple Sclerosis has been won – with Pharmac agreeing to fund Aotearoa New Zealand’s first ever treatment for the disease variant from October […]